A clinical trial to study the effect of two combinations, Telmisartan+ Amlodipine +Hydrochlorothiazide and Telmisartan + Hydrochlorothiazide
Phase 3
Completed
- Registration Number
- CTRI/2010/091/000494
- Lead Sponsor
- Aristo Pharmaceuticals Pvt Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 220
Inclusion Criteria
Males or Females with essential hypertension (SBP 140-200 mmHg DBP 90-120 mmHg), age >18 yrs, wiiling to follow up and informed consent, etc
Exclusion Criteria
Pregnant, lactating women, secondary hypertension,uncontrolled diabetes, etc
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method